TLR-2 Recognizes Propionibacterium acnes CAMP Factor 1 from Highly Inflammatory Strains

…, G Ollagnier, P Morand, N Désiré, S Sayon… - PloS one, 2016 - journals.plos.org
Background Propionibacterium acnes (P. acnes) is an anaerobic, Gram-positive bacteria
encountered in inflammatory acne lesions, particularly in the pilosebaceous follicle. P. acnes …

Spike gene evolution and immune escape mutations in patients with mild or moderate forms of COVID-19 and treated with monoclonal antibodies therapies

A Jary, S Marot, A Faycal, S Leon, S Sayon, K Zafilaza… - Viruses, 2022 - mdpi.com
We explored the molecular evolution of the spike gene after the administration of anti-spike
monoclonal antibodies in patients with mild or moderate forms of COVID-19. Four out of the …

Impact of Y143 HIV-1 Integrase Mutations on Resistance to Raltegravir In Vitro and In Vivo

…, F Simon, I Malet, C Alloui, S Sayon… - Antimicrobial agents …, 2010 - Am Soc Microbiol
Integrase (IN), the HIV-1 enzyme responsible for the integration of the viral genome into the
chromosomes of infected cells, is the target of the recently approved antiviral raltegravir (RAL…

Partially active HIV-1 Vif alleles facilitate viral escape from specific antiretrovirals

…, I Malet, M Binka, S Boukobza, M Wirden, S Sayon… - Aids, 2010 - journals.lww.com
Background: The HIV-1 Vif protein counteracts the antiviral activity of the cytidine deaminases
APOBEC3G and APOBEC3F. Natural variation in Vif may result in reduced efficacy …

[HTML][HTML] Prevalence of cervical HPV infection, sexually transmitted infections and associated antimicrobial resistance in women attending cervical cancer screening in …

…, L Beauvais-Remigereau, S Sayon… - International Journal of …, 2021 - Elsevier
Objectives To assess the prevalence of sexually transmitted infections (STIs), antimicrobial
resistance and cervical lesions among women from Sikasso, Mali. Methods Women infected …

The 501Y. V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y. V1 and the historical variants in nasopharyngeal samples from newly diagnosed …

…, V Ferre, S Marot, A Jary, S Sayon… - Journal of …, 2021 - journalofinfection.com
The pandemic of severe-acute-respiratory-syndromecoronavirus-2 (SARS-CoV-2) has
precipitated the most extensive global vaccine development programme in history and has …

E138K and M184I mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposure

…, C Soulie, M Wirden, P Flandre, DB Fofana, S Sayon… - Aids, 2012 - journals.lww.com
Background: Recent clinical trials with rilpivirine combined with emtricitabine and tenofovir
revealed that patients failing treatment, frequently, harbored viruses encoding resistance-…

Higher efficacy of nevirapine than efavirenz to achieve HIV-1 plasma viral load below 1 copy/ml

…, P Flandre, N Valin, S Fourati, S Sayon… - Aids, 2011 - journals.lww.com
Objectives: To compare the level of HIV-1 residual viremia, defined by a viral load below 50
copies/ml in patients receiving a tenofovir/emtricitabine and nevirapine (NVP) or efavirenz (…

Spike protein genetic evolution in patients at high-risk of severe COVID-19 treated by monoclonal antibodies

…, A Fauchois, E Ghidaoui, S Sayon… - Journal of …, 2023 - hal.sorbonne-universite.fr
High-risk patients, often immunocompromised and not responding to vaccine, continue to
experience severe COVID-19 and death. Monoclonal antibodies (mAbs) were shown effective …

Long-term evolution of humoral immune response after SARS-CoV-2 infection

E Teyssou, K Zafilaza, S Sayon, S Marot… - Clinical Microbiology …, 2022 - Elsevier
Objective We aimed to characterize the evolution of humoral immune response up to 1 year
after SARS-CoV-2 infection in healthcare workers (HCWs) during the first wave of COVID-19 …